Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Apple posts strong hardware momentum and record services, while Palantir accelerates AI platform growth. The debate c...
As AI hardware demand strengthens, the buy everything ai strategy draws renewed attention. AIQ has posted double-digi...
Meta Platforms faces a heavy AI investment cycle that could weigh on near-term cash flow, even as revenue climbs. Thi...
Choosing exposure to AI through tech ETFs doesn't have to be hard. This guide compares XLK and VGT, focusing on which...
As Synopsys reports strong Q2 results, investors weigh AI-driven catalysts against a heavy debt load and amortization...
SQQQ has endured sustained daily reset losses that compound over time, erasing most of its value even as the Nasdaq-1...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
Two former governors unite to tackle AI-related job losses with a bipartisan plan emphasizing retraining, wage suppor...
SpaceX began trading with high expectations and big swings. This article breaks down the moves from $135 to $154, exp...
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
Opendoor and Offerpad led a narrow iBuyer rally with midday gains of about 7% and 6%, respectively. The move comes as...